Monopar Therapeutics
MNPR
#8837
Rank
A$0.13 B
Marketcap
$25.60
Share price
7.31%
Change (1 day)
780.34%
Change (1 year)

Earnings for Monopar Therapeutics (MNPR)

Earnings in 2024 (TTM): -A$10.79 Million

According to Monopar Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$12.75 Million, an increase over its 2022 earnings that were of -A$15.96 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Monopar Therapeutics from 2017 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$10.79 Million-15.39%
2023 -A$12.75 Million-20.1%
2022 -A$15.96 Million15.52%
2021 -A$13.81 Million44.39%
2020 -A$9.57 Million49.23%
2019 -A$6.41 Million28.04%
2018 -A$5.01 Million-80.07%
2017 -A$25.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.19 Billion 1,656.23%๐Ÿ‡บ๐Ÿ‡ธ USA